https://oncbrain.oncologytoolkit.com/ AI-summarized oncology meeting studies, curated by a subspecialist. One item per study. en Mon, 29 Jun 2026 00:00:00 GMT https://oncbrain.oncologytoolkit.com/2026-06-29/#bart https://oncbrain.oncologytoolkit.com/2026-06-29/#bart Mon, 29 Jun 2026 00:00:00 GMT bladder [Challenges SOC] 2y locoregional FFS 87.1% vs 76.0% (HR 0.43, p=0.04) with adjuvant pelvic RT post-cystectomy; OS not significant (HR 0.78, p=0.31). Eligible: High-risk (T3-4/N+/R+) MIBC, post-cystectomy + chemo, no immunotherapy